• Molecular NameVecuronium
  • SynonymNA
  • Weight557.84
  • Drugbank_IDDB01339
  • ACS_NO50700-72-6
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)1.26
  • pkaN/A
  • LogD (pH=7, predicted)-0.04
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.26
  • LogSw (predicted, AB/LogsW2.0)7.17
  • Sw (mg/ml) (predicted, ACD/Labs)34.69
  • No.of HBond Donors0
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds6
  • TPSA55.84
  • StatusFDA approved
  • AdministrationIntravenous
  • PharmacologyA muscle relaxant in the category of non-depolarizing blocking agents.
  • Absorption_value0.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability0.0
  • Protein binding69.0
  • Volume of distribution (VD)0.19~0.51 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life0.6~2.8 h
  • ExcretionFecal (40-75%) and renal (30% as unchanged drug and metabolites)
  • Urinary Excretion20
  • Clerance3.0~6.4 ml/min/kg
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A